| . | Schizophrenia patients (n = 22) . | Controls (n = 26) . | All participants(n = 48) . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Standard trials . | Delayed trials . | Standard trials . | Delayed trials . | Standard trials . | Delayed trials . | |||||||
| Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | |
| Antisaccade error rate (%) | 34.4 (22.9) | 28.4 (20.4) | 3.7 (5.1) | 8.0 (12.8) | 23.7 (15.2) | 16.7 (13.5) | 3.9 (6.5) | 1.2 (3.5) | 29.1 (19.1) | 22.6 (17.0) | 3.8 (5.8) | 4.6 (8.2) |
| Antisaccade latency (ms) | 361.09 (56.69) | 353.78 (64.90) | 225.93 (77.31) | 216.52 (61.70) | 399.00 (66.23) | 362.73 (55.62) | 241.02 (52.73) | 210.62 (34.52) | 380.05 (61.46) | 358.26 (60.26) | 233.48 (65.02) | 213.57 (48.11) |
| Prosaccade latency (ms) | 283.65 (71.67) | 289.43 (62.86) | 230.97 (61.88) | 222.53 (58.89) | 310.10 (46.36) | 302.12 (44.56) | 232.81 (43.05) | 219.38 (38.57) | 296.88 (59.02) | 295.76 (53.71) | 231.89 (52.47) | 220.96 (48.73) |
| . | Schizophrenia patients (n = 22) . | Controls (n = 26) . | All participants(n = 48) . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Standard trials . | Delayed trials . | Standard trials . | Delayed trials . | Standard trials . | Delayed trials . | |||||||
| Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | |
| Antisaccade error rate (%) | 34.4 (22.9) | 28.4 (20.4) | 3.7 (5.1) | 8.0 (12.8) | 23.7 (15.2) | 16.7 (13.5) | 3.9 (6.5) | 1.2 (3.5) | 29.1 (19.1) | 22.6 (17.0) | 3.8 (5.8) | 4.6 (8.2) |
| Antisaccade latency (ms) | 361.09 (56.69) | 353.78 (64.90) | 225.93 (77.31) | 216.52 (61.70) | 399.00 (66.23) | 362.73 (55.62) | 241.02 (52.73) | 210.62 (34.52) | 380.05 (61.46) | 358.26 (60.26) | 233.48 (65.02) | 213.57 (48.11) |
| Prosaccade latency (ms) | 283.65 (71.67) | 289.43 (62.86) | 230.97 (61.88) | 222.53 (58.89) | 310.10 (46.36) | 302.12 (44.56) | 232.81 (43.05) | 219.38 (38.57) | 296.88 (59.02) | 295.76 (53.71) | 231.89 (52.47) | 220.96 (48.73) |
Data represent means (s.d.).
| . | Schizophrenia patients (n = 22) . | Controls (n = 26) . | All participants(n = 48) . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Standard trials . | Delayed trials . | Standard trials . | Delayed trials . | Standard trials . | Delayed trials . | |||||||
| Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | |
| Antisaccade error rate (%) | 34.4 (22.9) | 28.4 (20.4) | 3.7 (5.1) | 8.0 (12.8) | 23.7 (15.2) | 16.7 (13.5) | 3.9 (6.5) | 1.2 (3.5) | 29.1 (19.1) | 22.6 (17.0) | 3.8 (5.8) | 4.6 (8.2) |
| Antisaccade latency (ms) | 361.09 (56.69) | 353.78 (64.90) | 225.93 (77.31) | 216.52 (61.70) | 399.00 (66.23) | 362.73 (55.62) | 241.02 (52.73) | 210.62 (34.52) | 380.05 (61.46) | 358.26 (60.26) | 233.48 (65.02) | 213.57 (48.11) |
| Prosaccade latency (ms) | 283.65 (71.67) | 289.43 (62.86) | 230.97 (61.88) | 222.53 (58.89) | 310.10 (46.36) | 302.12 (44.56) | 232.81 (43.05) | 219.38 (38.57) | 296.88 (59.02) | 295.76 (53.71) | 231.89 (52.47) | 220.96 (48.73) |
| . | Schizophrenia patients (n = 22) . | Controls (n = 26) . | All participants(n = 48) . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Standard trials . | Delayed trials . | Standard trials . | Delayed trials . | Standard trials . | Delayed trials . | |||||||
| Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | Placebo . | Nicotine . | |
| Antisaccade error rate (%) | 34.4 (22.9) | 28.4 (20.4) | 3.7 (5.1) | 8.0 (12.8) | 23.7 (15.2) | 16.7 (13.5) | 3.9 (6.5) | 1.2 (3.5) | 29.1 (19.1) | 22.6 (17.0) | 3.8 (5.8) | 4.6 (8.2) |
| Antisaccade latency (ms) | 361.09 (56.69) | 353.78 (64.90) | 225.93 (77.31) | 216.52 (61.70) | 399.00 (66.23) | 362.73 (55.62) | 241.02 (52.73) | 210.62 (34.52) | 380.05 (61.46) | 358.26 (60.26) | 233.48 (65.02) | 213.57 (48.11) |
| Prosaccade latency (ms) | 283.65 (71.67) | 289.43 (62.86) | 230.97 (61.88) | 222.53 (58.89) | 310.10 (46.36) | 302.12 (44.56) | 232.81 (43.05) | 219.38 (38.57) | 296.88 (59.02) | 295.76 (53.71) | 231.89 (52.47) | 220.96 (48.73) |
Data represent means (s.d.).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
